milnacipran
Selected indexed studies
- Milnacipran for the Treatment of Fibromyalgia. (Health Psychol Res, 2021) [PMID:34746490]
- Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant. (Australas Psychiatry, 2018) [PMID:30198305]
- Milnacipran for neuropathic pain in adults. (Cochrane Database Syst Rev, 2015) [PMID:26148202]
_Worker-drafted node — pending editorial review._
Connections
milnacipran is a side effect of
Sources
- Milnacipran for the Treatment of Fibromyalgia. (2021) pubmed
- Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant. (2018) pubmed
- Milnacipran for neuropathic pain in adults. (2015) pubmed
- Milnacipran for pain in fibromyalgia in adults. (2015) pubmed
- Milnacipran. A review of its use in depression. (1998) pubmed
- Milnacipran: beyond a role of antidepressant. (2009) pubmed
- Preclinical pharmacology of milnacipran. (1996) pubmed
- Milnacipran versus other antidepressive agents for depression. (2009) pubmed
- Milnacipran for treatment of fibromyalgia. (2010) pubmed
- Milnacipran for neuropathic pain and fibromyalgia in adults. (2012) pubmed